Agenus Inc News and Q2 Results for 201
Agenus (AGEN) announced results with better than usual news including the following:
- $200 million received from BMS for anti-TIGIT bispecific antibody collaboration
- FDA cleared IND for AGEN1777 clinical enrollment
- AGEN1181 rapidly advancing in the clinic - data to be presented in 2H 2021
- Cell therapy . . .
This content is for paid subscribers.Today’s Highlights August 9, 2021